News | April 29, 2023
Evonik starts construction of new U.S. facility for pharmaceutical lipids
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Integration of modern and traditional medicine to facilitate the illness to wellness journey
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Time to combine innovation, access and technology to deliver positive patient outcomes
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
Profit After Tax (PAT) for the quarter ended December 31, 2022 was at Rs. 290.8 crore as compared to Rs. 239.8 crore in the previous corresponding quarter, registering a growth of 21.3% YoY
Subscribe To Our Newsletter & Stay Updated
